As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

A spike in M&A activity and stock prices have pulled biotech out of a yearslong downturn. But regulatory tumult and fierce ...

The Global Biotech Handbook offers opportunities in the biotech sector by detailing regulatory landscapes, clinical trial procedures, intellectual property issues, and market structures across 70 ...

The European Directory of Biotechnology Companies offers key market opportunities by providing access to 2,000 biotech companies and 5,000 executives. It assists in pinpointing decision-makers, ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

New Haven's cluster of data-driven drug-discovery startups could anchor new growth, a company founder says.

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Philadelphia’s biotechnology industry is facing a wave of uncertainty, as several ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

The Direxion Daily S&P Biotech Bear 3X Shares ETF offers -3X daily leverage to the S&P Biotechnology Select Industry Index, primarily attracting short-term traders. LABD has lost 99.98% of its value ...

South Korea could significantly strengthen the competitiveness of its bio-health industry by leveraging its abundant, high-quality bio data through artificial intelligence (AI), a central bank report ...

Raise large amounts of capital with an initial public offering, burn cash while navigating clinical trials, then submit a new ...